Stay updated on Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma Clinical Trial page.
Latest updates to the Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma Clinical Trial page
- Check6 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check13 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for those who can answer questions about joining the study, along with a reference to the Contacts and Locations section.SummaryDifference3%
- Check20 days agoChange DetectedThe phrase 'This study has 1 location' has been added, while the version with a comma has been removed.SummaryDifference0.4%
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe website has added new features for user interaction, while several detailed data fields and options for downloading study information have been removed.SummaryDifference4%
- Check36 days agoChange DetectedSeveral key health-related links have been removed, including those from NIH and Dailymed, which may impact access to information on rare diseases and specific medications.SummaryDifference0.4%
- Check43 days agoChange DetectedThe website has been updated to version 2.12.2, adding several new resources related to rare diseases and clinical trials, including links to detailed drug information for Ipilimumab and Nivolumab.SummaryDifference4%
Stay in the know with updates to Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma Clinical Trial page.